The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
ZEB/miR‐200 feedback loop: At the crossroads of signal transduction in cancer
Open accessAbstract
Embryonic differentiation programs of epithelial–mesenchymal and mesenchymal–epithelial transition (EMT and MET) represent a mechanistic basis for epithelial cell plasticity implicated in cancer. Transcription factors of the ZEB protein family (ZEB1 and ZEB2) and several microRNA species (predominantly miR‐200 family members) form a double negative feedback loop, which controls EMT and MET programs in both development and tumorigenesis. In this article, we review crosstalk between the ZEB/miR‐200 axis and several signal transduction pathways activated at different stages of tumor development. The close association of ZEB proteins with these pathways is indirect evidence for the involvement of a ZEB/miR‐200 loop in tumor initiation, progression and spread. Additionally, the configuration of signaling pathways involving ZEB/miR‐200 loop suggests that ZEB1 and ZEB2 may have different, possibly even opposing, roles in some forms of human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121 · cited 2×
“The molecular hallmarks of EMT programs are loss of epithelial cadherin and other junction proteins and de novo expression of mesenchymal markers, such as vimentin, N-cadherin and S100A4.(1,2) EMT programs operate at early (gastrulation, neural crest delamination) or late (organ formation) stages of embryonic developm…”
BackgroundEpithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,012
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
Singh, A., & Settleman, J. (2010) · Oncogene · doi:10.1038/onc.2010.215 · Cited by 2,545
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
Wellner, U., Schubert, J., Burk, U. C., Schmalhofer, O., Zhu, F., Sonntag, A., Waldvogel, B., Vannier, C., Darling, D., Hausen, A. Z., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1998 · Cited by 1,699
Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,645
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Morel, A.-P., Lièvre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002888 · Cited by 1,645
Migrating cancer stem cells — an integrated concept of malignant tumour progression
Brabletz, T., Jung, A., Spaderna, S., Hlubek, F., & Kirchner, T. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1694 · Cited by 1,352
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Shimono, Y., Zabala, M., Cho, R. W., Lobo, N., Dalerba, P., Qian, D., Diehn, M., Liu, H., Panula, S. P., Chiao, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.07.011 · Cited by 1,213
Systemic Spread Is an Early Step in Breast Cancer
Hüsemann, Y., Geigl, J. B., Schubert, F., Musiani, P., Meyer, M., Burghart, E., Forni, G., Eils, R., Fehm, T., Riethmüller, G., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.003 · Cited by 1,188
Parallel progression of primary tumours and metastases
Klein, C. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2627 · Cited by 1,133
Bracken, C. P., Gregory, P. A., Kolesnikoff, N., Bert, A. G., Wang, J., Shannon, M. F., & Goodall, G. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1942 · Cited by 1,060
Snail blocks the cell cycle and confers resistance to cell death
Vega, S., Morales, A. V., Ocaña, O. H., Valdés, F., Fabregat, I., & Nieto, M. A. (2004) · Genes & Development · doi:10.1101/gad.294104 · Cited by 867
Singh, A., Greninger, P., Rhodes, D., Koopman, L., Violette, S., Bardeesy, N., & Settleman, J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.022 · Cited by 841
Notch signaling mediates hypoxia-induced tumor cell migration and invasion
Sahlgren, C., Gustafsson, M. V., Jin, S., Poellinger, L., & Lendahl, U. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802047105 · Cited by 823
The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?
Brabletz, S., & Brabletz, T. (2010) · EMBO reports · doi:10.1038/embor.2010.117 · Cited by 793
Wnt/β-catenin signaling in cancer stemness and malignant behavior
Fodde, R., & Brabletz, T. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.007 · Cited by 785
p53 regulates epithelial–mesenchymal transition and stem cell properties through modulating miRNAs
Chang, C.-J., Chao, C.-H., Xia, W., Yang, J.-Y., Xiong, Y., Li, C.-W., Yu, W.-H., Rehman, S. K., Hsu, J. L., Lee, H.-H., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2173 · Cited by 745
Ansieau, S., Bastid, J., Doreau, A., Morel, A.-P., Bouchet, B. P., Thomas, C., Fauvet, F., Puisieux, I., Doglioni, C., Piccinin, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.005 · Cited by 715
Kato, M., Zhang, J., Wang, M., Lanting, L., Yuan, H., Rossi, J. J., & Natarajan, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611192104 · Cited by 699
Oft, M., Peli, J., Rudaz, C., Schwarz, H., Beug, H., & Reichmann, E. (1996) · Genes & Development · doi:10.1101/gad.10.19.2462 · Cited by 681
Karreth, F. A., Tay, Y., Perna, D., Ala, U., Tan, S. M., Rust, A. G., DeNicola, G., Webster, K. A., Weiss, D., Perez-Mancera, P. A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.032 · Cited by 653
Vincent, T., Neve, E. P. A., Johnson, J. R., Kukalev, A., Rojo, F., Albanell, J., Pietras, K., Virtanen, I., Philipson, L., Leopold, P. L., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1905 · Cited by 650
Korpal, M., Ell, B. J., Buffa, F. M., Ibrahim, T., Blanco, M. A., Celià-Terrassa, T., Mercatali, L., Khan, Z., Goodarzi, H., Hua, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2401 · Cited by 636
Brown, R. L., Reinke, L. M., Damerow, M. S., Perez, D., Chodosh, L. A., Yang, J., & Cheng, C. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44540 · Cited by 631
Wang, Z., Li, Y., Kong, D., Banerjee, S., Ahmad, A., Azmi, A. S., Ali, S., Abbruzzese, J. L., Gallick, G. E., & Sarkar, F. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4312 · Cited by 619
miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions
Siemens, H., Jackstadt, R., Hünten, S., Kaller, M., Menssen, A., Götz, U., & Hermeking, H. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18552 · Cited by 609
Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer
Sempere, L. F., Christensen, M., Silahtaroglu, A., Bak, M., Heath, C. V., Schwartz, G., Wells, W., Kauppinen, S., & Cole, C. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-5019 · Cited by 574
Gregory, P. A., Bracken, C. P., Smith, E., Bert, A. G., Wright, J. A., Roslan, S., Morris, M., Wyatt, L., Farshid, G., Lim, Y.-Y., et al. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-02-0103 · Cited by 552
p53 regulates epithelial–mesenchymal transition through microRNAs targeting ZEB1 and ZEB2
Kim, T., Veronese, A., Pichiorri, F., Lee, T. J., Jeon, Y.-J., Volinia, S., Pineau, P., Marchio, A., Palatini, J., Suh, S.-S., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110235 · Cited by 514
Gibbons, D. L., Lin, W., Creighton, C. J., Rizvi, Z. H., Gregory, P. A., Goodall, G. J., Thilaganathan, N., Du, L., Zhang, Y., Pertsemlidis, A., et al. (2009) · Genes & Development · doi:10.1101/gad.1820209 · Cited by 512
MicroRNAs as regulators of epithelial-mesenchymal transition
Gregory, P. A., Bracken, C. P., Bert, A. G., & Goodall, G. J. (2008) · Cell Cycle · doi:10.4161/cc.7.20.6851 · Cited by 506
The role of the ZEB family of transcription factors in development and disease
Vandewalle, C., Van Roy, F., & Berx, G. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8465-8 · Cited by 486
Spaderna, S., Schmalhofer, O., Hlubek, F., Berx, G., Eger, A., Merkel, S., Jung, A., Kirchner, T., & Brabletz, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.016 · Cited by 476
Leong, K. G., Niessen, K., Kulic, I., Raouf, A., Eaves, C., Pollet, I., & Karsan, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071082 · Cited by 467
Shapiro, I. M., Cheng, A. W., Flytzanis, N. C., Balsamo, M., Condeelis, J. S., Oktay, M. H., Burge, C. B., & Gertler, F. B. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002218 · Cited by 461
Sánchez-Tilló, E., de Barrios, O., Siles, L., Cuatrecasas, M., Castells, A., & Postigo, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108977108 · Cited by 448
Evdokimova, V., Tognon, C., Ng, T., Ruzanov, P., Melnyk, N., Fink, D., Sorokin, A., Ovchinnikov, L. P., Davicioni, E., Triche, T. J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.017 · Cited by 444
ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility
Vial, E., Sahai, E., & Marshall, C. J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00162-4 · Cited by 406
Rational targeting of Notch signaling in cancer
Rizzo, P., Osipo, C., Foreman, K., Golde, T., Osborne, B., & Miele, L. (2008) · Oncogene · doi:10.1038/onc.2008.226 · Cited by 395
Hurteau, G. J., Carlson, J. A., Spivack, S. D., & Brock, G. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1058 · Cited by 390
Postigo, A. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg226 · Cited by 387
An ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transition
Warzecha, C. C., Jiang, P., Amirikian, K., Dittmar, K. A., Lu, H., Shen, S., Guo, W., Xing, Y., & Carstens, R. P. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.195 · Cited by 383
The ZEB1/miR‐200 feedback loop controls Notch signalling in cancer cells
Brabletz, S., Bajdak, K., Meidhof, S., Burk, U., Niedermann, G., Firat, E., Wellner, U., Dimmler, A., Faller, G., Schubert, J., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.349 · Cited by 369
Multiple Tumor Suppressor Pathways Negatively Regulate Telomerase
Lin, S.-Y., & Elledge, S. J. (2003) · Cell · doi:10.1016/s0092-8674(03)00430-6 · Cited by 363
Shirakihara, T., Saitoh, M., & Miyazono, K. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-03-0249 · Cited by 320
Zeb1 links epithelial-mesenchymal transition and cellular senescence
Liu, Y., El-Naggar, S., Darling, D. S., Higashi, Y., & Dean, D. C. (2008) · Development · doi:10.1242/dev.007047 · Cited by 303
TRPS1 Targeting by miR-221/222 Promotes the Epithelial-to-Mesenchymal Transition in Breast Cancer
Stinson, S., Lackner, M. R., Adai, A. T., Yu, N., Kim, H.-J., O’Brien, C., Spoerke, J., Jhunjhunwala, S., Boyd, Z., Januario, T., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001538 · Cited by 303
Shin, S., Dimitri, C. A., Yoon, S.-O., Dowdle, W., & Blenis, J. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.02.020 · Cited by 291
Postovit, L.-M., Margaryan, N. V., Seftor, E. A., Kirschmann, D. A., Lipavsky, A., Wheaton, W. W., Abbott, D. E., Seftor, R. E. B., & Hendrix, M. J. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800467105 · Cited by 286
Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas
Braun, J., Hoang-Vu, C., Dralle, H., & Hüttelmaier, S. (2010) · Oncogene · doi:10.1038/onc.2010.169 · Cited by 282
Li, A., Omura, N., Hong, S.-M., Vincent, A., Walter, K., Griffith, M., Borges, M., & Goggins, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4227 · Cited by 272
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer
Olson, P., Lu, J., Zhang, H., Shai, A., Chun, M. G., Wang, Y., Libutti, S. K., Nakakura, E. K., Golub, T. R., & Hanahan, D. (2009) · Genes & Development · doi:10.1101/gad.1820109 · Cited by 260
Shirakihara, T., Horiguchi, K., Miyazawa, K., Ehata, S., Shibata, T., Morita, I., Miyazono, K., & Saitoh, M. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.351 · Cited by 227
Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer
Berx, G., Raspé, E., Christofori, G., Thiery, J. P., & Sleeman, J. P. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9114-6 · Cited by 226
Krafchak, C. M., Pawar, H., Moroi, S. E., Sugar, A., Lichter, P. R., Mackey, D. A., Mian, S., Nairus, T., Elner, V., Schteingart, M. T., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/497348 · Cited by 226
Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression
Wendt, M. K., Tian, M., & Schiemann, W. P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1199-1 · Cited by 210
TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP
Horiguchi, K., Sakamoto, K., Koinuma, D., Semba, K., Inoue, A., Inoue, S., Fujii, H., Yamaguchi, A., Miyazawa, K., Miyazono, K., et al. (2012) · Oncogene · doi:10.1038/onc.2011.493 · Cited by 209
Comparative oncogenomics identifies breast tumors enriched in functional tumor-initiating cells
Herschkowitz, J. I., Zhao, W., Zhang, M., Usary, J., Murrow, G., Edwards, D., Knezevic, J., Greene, S. B., Darr, D., Troester, M. A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018862108 · Cited by 209
Mejlvang, J., Kriajevska, M., Vandewalle, C., Chernova, T., Sayan, A. E., Berx, G., Mellon, J. K., & Tulchinsky, E. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-05-0406 · Cited by 207
Self-citationYang, Y., Ahn, Y.-H., Gibbons, D. L., Zang, Y., Lin, W., Thilaganathan, N., Alvarez, C. A., Moreira, D. C., Creighton, C. J., Gregory, P. A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42579 · Cited by 196
Lu, J., Guo, H., Treekitkarnmongkol, W., Li, P., Zhang, J., Shi, B., Ling, C., Zhou, X., Chen, T., Chiao, P. J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.010 · Cited by 193
Sayan, A. E., Griffiths, T. R., Pal, R., Browne, G. J., Ruddick, A., Yagci, T., Edwards, R., Mayer, N. J., Qazi, H., Goyal, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902042106 · Cited by 192
Self-citationCancer stemness and metastasis: Therapeutic consequences and perspectives
Monteiro, J., & Fodde, R. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.02.030 · Cited by 186
Evolutionary functional analysis and molecular regulation of the ZEB transcription factors
Gheldof, A., Hulpiau, P., van Roy, F., De Craene, B., & Berx, G. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0935-3 · Cited by 177
miR-200b mediates post-transcriptional repression of ZFHX1B
Christoffersen, N. R., Silahtaroglu, A., Ørom, U. A., Kauppinen, S., & Lund, A. H. (2007) · RNA · doi:10.1261/rna.586807 · Cited by 175
TWISTing an embryonic transcription factor into an oncoprotein
Ansieau, S., Morel, A.-P., Hinkal, G., Bastid, J., & Puisieux, A. (2010) · Oncogene · doi:10.1038/onc.2010.92 · Cited by 167
Ohashi, S., Natsuizaka, M., Wong, G. S., Michaylira, C. Z., Grugan, K. D., Stairs, D. B., Kalabis, J., Vega, M. E., Kalman, R. A., Nakagawa, M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4614 · Cited by 164
Expanding roles of ZEB factors in tumorigenesis and tumor progression.
Sànchez‐Tilló, E., Siles, L., de Barrios, O., Cuatrecasas, M., Vaquero, E. C., Castells, A., & Postigo, A. A. (2011) · Europe PMC (PubMed Central) · Cited by 160
Vallejo, D. M., Caparros, E., & Dominguez, M. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.358 · Cited by 158
Kahlert, C., Lahes, S., Radhakrishnan, P., Dutta, S., Mogler, C., Herpel, E., Brand, K., Steinert, G., Schneider, M. A., Mollenhauer, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2816 · Cited by 153
Savagner, P., Vallés, A. M., Jouanneau, J., Yamada, K. M., & Thiery, J. P. (1994) · Molecular Biology of the Cell · doi:10.1091/mbc.5.8.851 · Cited by 133
Pollock, C. B., Shirasawa, S., Sasazuki, T., Kölch, W., & Dhillon, A. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1911 · Cited by 131
Zweier, C., Albrecht, B., Mitulla, B., et al. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10226 · Cited by 130
Chng, Z., Teo, A. K. K., Pedersen, R. A., & Vallier, L. (2010) · Cell stem cell · doi:10.1016/j.stem.2009.11.015 · Cited by 129
Fontemaggi, G., Gurtner, A., Strano, S., Higashi, Y., Sacchi, A., Piaggio, G., & Blandino, G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8461-8470.2001 · Cited by 127
Cancer Stem Cells and the Ontogeny of Lung Cancer
Peacock, C. D., & Watkins, D. N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2702 · Cited by 121
Goossens, S., Janzen, V., Bartunkova, S., Yokomizo, T., Drogat, B., Crisan, M., Haigh, K., Seuntjens, E., Umans, L., Riedt, T., et al. (2011) · Blood · doi:10.1182/blood-2010-08-300236 · Cited by 113
Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer
Shulewitz, M. J., Soloviev, I., Wu, T., Koeppen, H., Polakis, P. G., & Sakanaka, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209470 · Cited by 111
Aylon, Y., & Oren, M. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.002 · Cited by 106 · cited 1×
“p53 and its homologues p63 and p73 control cell cycle progression, apoptosis, senescence, differentiation and stemness.(101) p63 and p73 exist as full-sized proteins (TAp63 and TAp73) or truncated versions (DNp63 and DNp73), which lack transcriptional activation domains.”
BackgroundZEB proteins link cell motility with cell cycle control and cell survival in cancer
Browne, G. J., Sayan, E., & Tulchinsky, E. M. (2010) · Cell Cycle · doi:10.4161/cc.9.5.10839 · Cited by 99
Self-citationThe epithelial cell default‐phenotype hypothesis and its implications for cancer
Frisch, S. M. (1997) · BioEssays · doi:10.1002/bies.950190811 · Cited by 95
CCN5, a Novel Transcriptional Repressor of the Transforming Growth Factor β Signaling Pathway
Sabbah, M., Prunier, C., Ferrand, N., Megalophonos, V., Lambein, K., De Wever, O., Nazaret, N., Lachuer, J., Dumont, S., & Redeuilh, G. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01316-10 · Cited by 89
Miquelajáuregui, A., de Putte, T. V., Polyakov, A. S., Nityanandam, A., Boppana, S., Seuntjens, E., Karabinoš, A., Higashi, Y., Huylebroeck, D., & Tarabykin, V. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609863104 · Cited by 88
Potential mRNA Degradation Targets of hsa-miR-200c
Hurteau, G. J., Spivack, S. D., & Brock, G. (2006) · Cell Cycle · doi:10.4161/cc.5.17.3133 · Cited by 82
Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells
Tchernitsa, O. I., Sers, C., Zuber, J. A., Hinzmann, B., Grips, M., Schramme, A., Lund, P., Schwendel, A., Rosenthal, A., & Schäfer, R. (2004) · Oncogene · doi:10.1038/sj.onc.1207585 · Cited by 80
Arima, Y., Hayashi, H., Sasaki, M., Hosonaga, M., Goto, T. M., Chiyoda, T., Kuninaka, S., Shibata, T., Ohata, H., Nakagama, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.313759 · Cited by 75
Knouf, E. C., Garg, K. S., Arroyo, J. D., Correa, Y., Sarkar, D., Parkin, R. K., Wurz, K., O'Briant, K. C., Godwin, A. K., Urban, N. D., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr731 · Cited by 74
Hiles, G. L., Huang, W., Pal, A., Cabanillas, A. M., & Kleer, C. G. (2011) · Journal of Cell Science · doi:10.1242/jcs.084194 · Cited by 66
Huang, W., Zhang, Y., Varambally, S., Chinnaiyan, A. M., Banerjee, M., Merajver, S. D., & Kleer, C. G. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070899 · Cited by 63
Inducible expression of TGFβ, Snail and Zeb1 recapitulates EMT in vitro and in vivo in a NSCLC model
Argast, G. M., Krueger, J. S., Thomson, S., Sujka-Kwok, I., Carey, K., Silva, S., O’Connor, M., Mercado, P., Mulford, I. J., Young, G. D., et al. (2011) · Clinical & Experimental Metastasis · doi:10.1007/s10585-011-9394-8 · Cited by 63
Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells
Öztürk, N., Erdal, E., Mumcuoğlu, M., Akçalı, K. C., Yalcin-Ozuysal, Ö., Şentürk, Ş., Arslan-Ergül, A., Dedeoğlu, B. G., Yuluğ, I. G., Çetin-Atalay, R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510877103 · Cited by 61
Bui, T., Sequeira, J., Wen, T. C., Sola, A., Higashi, Y., Kondoh, H., & Genetta, T. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004373 · Cited by 53
Jenkins, R. L., Martin, J. T., Phillips, A. O., Bowen, T., & Fraser, D. J. (2012) · Biochemical Journal · doi:10.1042/bj20111861 · Cited by 48
Safina, A. F., Varga, A. E., Bianchi, A., Zheng, Q., Kunnev, D., Liang, P., & Bakin, A. V. (2009) · Cell Cycle · doi:10.4161/cc.8.2.7590 · Cited by 47
δEF1 repressor controls selectively p53 family members during differentiation
Fontemaggi, G., Gurtner, A., Damalas, A., Costanzo, A., Higashi, Y., Sacchi, A., Strano, S., Piaggio, G., & Blandino, G. (2005) · Oncogene · doi:10.1038/sj.onc.1208891 · Cited by 45
The zinc finger transcription factor ZFHX1A is linked to cell proliferation by Rb–E2F1
Liu, Y., Costantino, M. E., Montoya-Durango, D. E., Higashi, Y., Darling, D. S., & Dean, D. C. (2007) · Biochemical Journal · doi:10.1042/bj20070344 · Cited by 39
Longstreet, M., Miller, B., & Ph, H. (1992) · PubMed · Cited by 36
Cited by
Anoikis molecular pathways and its role in cancer progression
Paoli, P., Giannoni, E., & Chiarugi, P. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.06.026 · Cited by 1,160
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
Epithelial–Mesenchymal Plasticity: A Central Regulator of Cancer Progression
Ye, X., & Weinberg, R. A. (2015) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.07.012 · Cited by 1,013
Serrano-Gomez, S. J., Maziveyi, M., & Alahari, S. K. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0502-x · Cited by 814
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
Jolly, M. K. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00155 · Cited by 693
Metadata
- Authors
- Hill, L., Browne, G., & Tulchinsky, E.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2012-07-21
- Volume
- 132
- Issue
- 4
- Pages
- 745-754
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2091996935
- Cited by
- 261
- References
- 107
- FWCI
- 6.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.